Paper11136348
Effects of the non-selective phosphodiesterase inhibitor pentoxifylline on regional cerebral blood flow and large arteries in healthy subjects.
Kruuse C and 6 others. Eur J Neurol, 2000. Cited by 23 papers, by iCite.
Cite this record
ConductScience Library. Effects of the non-selective phosphodiesterase inhibitor pentoxifylline on regional cerebral blood flow and large arteries in healthy subjects. Papers, record 11136348. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11136348
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effects of the non-selective phosphodiesterase inhibitor pentoxifylline on regional cerebral blood flow and large arteries in healthy subjects.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain | Major topic |
| Middle Cerebral Artery | Major topic |
| Pentoxifylline | Major topic |
| Adult | |
| Blood Flow Velocity | |
| Blood Pressure | |
| Cross-Over Studies | |
| Double-Blind Method | |
| Female | |
| Heart Rate | |
| Humans | |
| Male | |
| Phosphodiesterase Inhibitors | |
| Pilot Projects | |
| Reference Values | |
| Regional Blood Flow | |
| Ultrasonography, Doppler, Transcranial |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40002394 | Oxidative Mechanism of Peyronie's Disease and Effectiveness of Pentoxifylline in the Therapeutic Management: A Narrative Review. | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/40002394 | PubMed |
| 39765810 | Protective Effect of Pentoxifylline on the Development of Acute Gastric Mucosal Injury in a Model of LPS-Induced Sepsis. | Antioxidants (Basel) | 2024 | https://conductscience.org/library/papers/39765810 | PubMed |
| 36555611 | Role of Oxidative Stress in Peyronie's Disease: Biochemical Evidence and Experiences of Treatment with Antioxidants. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36555611 | PubMed |
| 34669084 | Whole blood viscosity is associated with baseline cerebral perfusion in acute ischemic stroke. | Neurol Sci | 2022 | https://conductscience.org/library/papers/34669084 | PubMed |
| 28730281 | PK/PD studies on non-selective PDE inhibitors in rats using cAMP as a marker of pharmacological response. | Naunyn Schmiedebergs Arch Pharmacol | 2017 | https://conductscience.org/library/papers/28730281 | PubMed |
| 23403374 | Sources of variability of resting cerebral blood flow in healthy subjects: a study using ¹³³Xe SPECT measurements. | J Cereb Blood Flow Metab | 2013 | https://conductscience.org/library/papers/23403374 | PubMed |
| 22284589 | Autonomic cerebral vascular response to sildenafil in diabetic patient. | Diabetol Metab Syndr | 2012 | https://conductscience.org/library/papers/22284589 | PubMed |
| 20590585 | Mechanisms mediating the ability of caffeine to influence MDMA ('Ecstasy')-induced hyperthermia in rats. | Br J Pharmacol | 2010 | https://conductscience.org/library/papers/20590585 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/11136348
GET https://conductscience.org/api/papers/v1/11136348/authors